chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Periodic headaches; Extreme neck pain; Back pain; Thigh pain. Moderate pain in right arm: injection location.; Mild pain inside ears.; Mild sore throat; Moderate fatigue.; Mild tightening of chest.; This is a spontaneous report from a contactable reporter (consumer). The reporter is the patient.   A 55-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 03Jan2022 at 14:00 (Lot number: unknown) as dose 1, single for COVID-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19?:Yes. Concomitant medication(s) included: SHINGRIX taken for Immunisation, start date: 06Dec2021, stop date: 06Dec2021; TDAP taken for Immunisation, start date: 06Dec2021, stop date: 06Dec2021; PHENTERMINE; FLONASE and CLONAZEPAM.  The following information was reported: HEADACHE (non-serious) with onset 03Jan2022 at 18:00, outcome "recovering", described as "Began about 6:00pm: Approximately 3 hours after injection. Periodic headaches"; NECK PAIN (non-serious), BACK PAIN (non-serious), PAIN IN EXTREMITY (non-serious), EAR PAIN (non-serious), OROPHARYNGEAL PAIN (non-serious), FATIGUE (non-serious), CHEST DISCOMFORT (non-serious) all with onset 03Jan2022 at 18:00, outcome "recovering", and all described as "Extreme neck, back, thigh pain". Therapeutic measures were not taken as a result of headache, neck pain, back pain, pain in extremity, ear pain, oropharyngeal pain, fatigue and chest discomfort.  Additional information: The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient received other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.   The lot number for BNT162b2 was not provided and will be requested during follow up.
pt recvd vax; maculopapular rash erupted on anterior & posterior trunk & arm; dph given;
she felt  dizzy and weak she felt it was the pneumovax shot. she went to urgent care and the wait was so long she left and ended up feeling better later that night
2 weeks after receiving the first shot I menstruated for the first time in 2 years. I have gone through menopause already and take hormone replacement should I be concerned.
Started with soreness in arm that night. The next day, mild chills and body aches. That evening, I started to feel a tingling or trembling feeling in my chest and left arm. By the next day, it was also in my legs and I have been continuing to have this on and off. After the first day, the chills and body aches resolved. I have had on and off trembling in my extremities and my chest. Like an amped up electrified feeling. There has been several nights where I have slept very, very little. It's almost like my nervous system can't turn off and that I can't sleep at night. I did see my doctor and he talked about my lymph system going wild trying to do what it is suppose to do. I did have some very slight tenderness or awareness of lymph nodes in different areas in my body - armpits, in back of knees, groin area (lower abdomen) etc - that happened around 10/2 and 10/3. I am continuing to take supplements and take baths and try to drink lots of water and move around some. There are times when it's better but it's definitely worse at night when I'm not active. I feel it a lot at night and that is really bothersome. Doctor is having me wait it out.
2/15/23 I thought I had a head cold. I was coughing and had head congestion. On 2/20/23 I had a low- grade headache that resembled the headache I have when I have a low-grade fever. I did not have a fever. I took an at home COVID test and it was positive. I had a telehealth visit and he prescribed LAGEVRIO. I began taking the medication that day. On 2/24/23, I tested negative with an at home COVID test and have tested negative since.
?Moderna COVID-19 Vaccine EUA? About 5 minutes after injection I felt dizzy and lost consciousness for about 10 seconds before snapping back to it. My body was very shaky and I was really sweaty. Drinking water/juice and eating the cheese crackers helped me return to normal. I felt better by the time 15 minutes had passed since the injection.
Weak  Pain in chest  Rashes and swollen admit  On going Headaches Pain in mouth and face Red skin
Sharp pain behind right knee.  Subsided by evening.  Went to The ER  Sunday morning, Feb. 21.  They x-rayed leg and found nothing  unusual for a woman my age.  Then they conducted a scan and discovered a blood clot behind my knee.  Since then, I have had intermittent pain. The Doctor referred me to a hematologist which I will see this week.  Prior to the vaccination have never had a blood clot.  It occurred three days after the vaccination.  Coincidence?  I think not.
Patient called on 3/17 to report itchy rash on right arm, which is the arm that got High Dose Flu Shot. Recommended patient to get Benadryl and Cortisone cream. Will check back in couple days.
This spontaneous report was received from a health care worker regarding an unspecified number of patients of unknown age and gender. Patient demographics were not provided. Information on the concurrent conditions, medical history and drug allergies of the patients were not reported. On unknown date, unspecified number of patients were administered unspecified number of improperly stored doses of VARIVAX (Merck) lot # L044527, expiry date 09-NOV-2017 (dose number, dose, frequency, route and anatomical location were not specified) (incorrect product storage). Concomitant medication were not specified. There were no adverse effects reported. There was no product Quality Complaint (PQC) involved. Vaccine was stored at temperature of -0.1 degree Centigrade for 11 hours, 45 minutes. There was no previous temperature excursion performed. Also GARDASIL 9 appeared in the product list as it was involved in the excursion, however no improperly stored doses of it were administered. This is one of several reports received from same reporter. Additional information has been requested.
Extreme painful flare of psoriasis on legs, still present, using triamcinolone acetonide to treat.
mom states got hives 13FEB92 was seen by MD dx HBOC shot rxn; TC to MD not a reaction to any shot given 12FEB92 just urticaria;
Patient reported a rash within 3 days of vaccine administration. Upon prompt evaluation by primary physician, it was determined to be an unusual case of chicken pox from the Shingrix vaccine.
Pt. called PPHD on 10/15/07 to report that she had a reaction to the Yellow Fever vaccination admin. on 10/1/07. Pt. stated that she had a localized rash with urticaria also stating "numbness" in arm 1-2 days afterwards. Pt. went to see PMD on 10/11/07 who measured the puritic area to be 8.5cm x 10cm on left arm. Pt. stated that rash was "getting better" but wanted to have the reaction reported to VAERS.
Touchy arms; This is a spontaneous report from a contactable consumer or other non hcp. A 73-years-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN,SINGLE for covid-19 immunisation; palbociclib (IBRANCE), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 125 mg for an unspecified indication. The patient medical history and  concomitant medications were not reported. The patient experienced touchy arms on an unspecified date. The action taken in response to the event for palbociclib was unknown. The outcome of the event was unknown.  No follow up attempts are needed. No further information is expected.
Had cold like symptoms and lots of phlegm, developed a cold sore. The coughing and runny nose went away after 7 days but the phlegm and headache have remained. The headache goes from mild to extreme especially at night
Patient reports prior to coming to clinic for jynneos vaccine, they received flu and covid-19 vaccines on 9/8/2022 at other unknown location. On 9/10/2022 patient received jynneos with clinic. On 9/12/2022 patient reports left sided chest pain-"really bad" and "very uncomfortable" in quality. On 9/13/2022 follow-up with patient was
pneumonia; got the flu; Initial information received on 10-Dec-2022 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp.  This case involves a patient  of an unknown gender patient who experienced pneumonia and got the flu, after receiving vaccine INFLUENZA VACCINE.  The patient's past medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (formulation, strength, site, route, lot number and expiry date: not reported) for prophylactic vaccination.  On an unknown date the patient developed a serious event of  pneumonia  and got the flu (influenza)(unknown latency) following the administration of INFLUENZA VACCINE. The event of pneumonia was assessed as medically significant.  The patient was hospitalized for both the events.  It is unknown if there were lab data/results available  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the events (pneumonia, got the flu).  Outcome: unknown for both the events; Sender's Comments: Sanofi company comment dated 14-Dec-2022: This case involves a patient  of an unknown gender patient who experienced pneumonia and got the flu, after receiving vaccine INFLUENZA VACCINE. Case will be reevaluated post further update on concomitant medications, past medical history, concurrent condition during vaccination, underlying disease and laboratory investigations excluding alternative etiologies for the reported event which will preclude a comprehensive assessment of this case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
expired Moderna Covid-19 Vaccine, "We gave it to 2 of our patients yesterday; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 Vaccine, "We gave it to 2 of our patients yesterday) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 071B22A) for COVID-19 prophylaxis.     Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:HCP declined to provide DOB.     On 16-Mar-2023, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 16-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 Vaccine, "We gave it to 2 of our patients yesterday) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 Vaccine, "We gave it to 2 of our patients yesterday) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported No concomitant medications were reported   This case was linked to US-MODERNATX, INC.-MOD-2023-715996 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-715996:same reporter
Initial and follow up information has been received from a consumer and a medical assistant and a consumer concerning the consumer's approximately 14 month old granddaughter with rhinitis allergic and a history of ear infection and eczema, and no known drug allergy who on 12-JAN-2010, in approximately March 2010 and on 11-MAY-2010 was vaccinated with the first dose, the second dose and the third dose of ROTATEQ respectively (Lot number of the third dose: 664880/1473Y) at the patient's 2, 4 and 6 months after birth as prescribed. Concomitant therapy included FLONASE and hydrocortisone (Manufacturer unknown). The consumer reported that the patient ended up testing positive for rotavirus on 2 occasions, once in January of 2011 and again in May 2011. The first time in January 2011, the patient was taken to the emergency room only and was not admitted. She was given supportive medications that were not named. The medical assistant reported that on 01-FEB-2011 the patient was seen in their office with symptoms of vomiting, loss of appetite and fuzziness of a few days duration. The medical assistant could not find any details about testing for rotavirus or for treatment. On 24-MAY-2011 the patient was seen in their office with symptoms of vomiting and diarrhea. The patient was admitted to hospital from 26-MAY-2011 to 28-MAY-2011. It was reported that discharge records showed diagnoses of dehydration and rotavirus. The consumer reported that the patient was given morphine as well as fluids for treatment. The patient's carbon dioxide level was down to 16 and testing for Rotavirus was positive. The patient was seen in the medical assistant's office on 07-JUN-2011 for "recheck" and follow-up blood work. On an unspecified date, the patient's dehydration and rotavirus had recovered, however it was unspecified whether the patient's loss of appetite and fuzziness recovered. The child had received a full immunization dosing schedule and was given the ROTATEQ as prescribed. The child would be tested for immune system issues as well as allergy testing at a later unspecified date. The medical assistant could not say if the events were disabling or life threatening. The health care professional contacted during telephone follow-up could not supply the following information: dates of vaccination and lot number. Additional information has been requested.
sore arm; low grade fever; fatigue; chest congestion; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (chest congestion), VACCINATION SITE PAIN (sore arm), PYREXIA (low grade fever) and FATIGUE (fatigue) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050E21A, 013L20A and 025J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Sep-2021, the patient experienced VACCINATION SITE PAIN (sore arm). In September 2021, the patient experienced CHEST DISCOMFORT (chest congestion), PYREXIA (low grade fever) and FATIGUE (fatigue). At the time of the report, CHEST DISCOMFORT (chest congestion), VACCINATION SITE PAIN (sore arm), PYREXIA (low grade fever) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Patient tested negative 3 times..         The patient was immunocompromised. No concomitant medications were provided. No treatment medications were provided.
sneezing 19DEC93, h/a, some sore throat & ear pain 20DEC; fainted @ school 20DE93AM; principal observed episode & stated pt had stiffness & shaking for 30 seconds slept for 1/2 hrs afterward; exam 20DEC93 @ 410PM nl x/for URI/ROM;
Superficial skin reaction (erythema and induration) left upper arm at injection site. Treated with cool compress, antihistamines.
Vaccine administered was outside of use window. Vaccine had been opened 04/21/2022 at 0920. Vaccine administered to this patient 04/22/2022 at 1440.
I experienced extreme fatigue, lightheadedness, and my boyfriend came home and found me on the floor where he was unable to rouse me. He stated it took around 5 minutes to rouse me. The symptoms of fatigue, lightheadedness, and brain fog lasted for 4 days before they abated. I have experienced mild lightheadedness off and on since dose 4 at random.
Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (Headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not provided. Treatment information included was acetaminophen 100mg occasionally when she was having the headache. The patient received the 1st dose of Moderna COVID-19 vaccine at Hospital.  This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Jan-2021 and was forwarded to Moderna on 23-Jan-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (Headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not provided. Treatment information included was acetaminophen 100mg occasionally when she was having the headache. The patient received the 1st dose of Moderna COVID-19 vaccine at Hospital.
19th July, Fever, unable to swallow or breathe for a minute or two. 28th July, Unable to swallow/breathe for a minute or two after lying down. Coughing constantly. Rash started 30th July on trunk, arms and thighs - still active daily as of 13th August.
numbness in left side of body.  First started in arm and hand, and then 5 days after vaccine numbness and tingling in left leg.
Narrative: COVID infection following COVID vaccine series 07/01 Janssen, dose #1 08/17 COVID swab, result: detected 08/17 PT result: 12.6 H 08/17 INR result: 1.13 H 08/17 BNP result: 177.9 H 08/17 TROPONIN I result: 0.032 H 08/17 DDIMER result: 2.22 H 08/17 ABG i-pH 7.53, i-PCO2 28.7, i-PO2 77, i-HCO3 23.8 08/17 CXR impression: Faint opacities in the right lower lung zone. 08/18 CXR impression: No significant interval change. 08/20 pt cc: No symptoms exposure: unknown 08/20 pt admit to medicine dx: Asymptomatic Covid-19 LOS: 7 days 08/27 ESR result: 57 H 08/27 clinically resolved
Patient seated in Observation area.   1740: Suddenly diaphoretic, complains of blurred vision, dizzy and a feeling of cold in his chest. 1740:- patient placed on floor/legs up. EMS in attendance; NP in attendance.  BP109/66; HR88; O2 96% on RA/ BS 118. EKG NSR 1741: patient more lucid. Answering questions 1742: patient able to drink water and eat a breakfast bar.  1817:  VS 124/82; HR 62; O2 sats on RA 97%/ EKG NSR 1823: Patient discharged from observation with Son to home. Walking on his own. A & Ox3
Patient was supposed to receive 0.3 ml of adult pfizer vaccine, instead received 0.3 ml of unconstituted pediatric pfizer vaccine.
No additional AE reported; temperature excursion; This spontaneous report has been received from a medical assistant, concerning a 4-year-old female patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided.  On 30-JAN-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rha) (PROQUAD) subcutaneous injection, right thigh, intramuscular (valid lot number W019627 [expiration date 19-DEC-2023 obtained per internal validation]) (dose, vaccination scheme, and frequency were not provided) for prophylaxis, after a temperature excursion. Total time in the range of -9 degrees Celsius (C) to 8 degrees C: 72 hours, 8 minutes. Total time at 26 degrees C or warmer: 2 hours.  Total combined excursion time: 74 hours, 8 minutes, 0 seconds (product storage error).  ~  No additional adverse events were provided.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2303USA002114:Original case
This spontaneous report as received from a pharmacist refers to a 60 year old female patient. None of pertinent medical history was reported. None of drug reactions/allergies was reported. On 15-SEP-2014 the patient was vaccinated with a dose of ZOSTAVAX (lot # K003600, expiry date: 10-MAR-2015), subcutaneous in the arm for vaccination (dose and dose number not reported). None of concomitant medication was reported. On 16-SEP-2014, the patient came back to the pharmacy and presented with an injection site reaction in the arm where she received the ZOSTAVAX. The reporting pharmacist reported that the patient stated that the site was painful, warm and tender, and the injection site reaction was about 6 inches across the injection site. Patient sought medical attention by returning to pharmacy and ice packs was given as treatment. None of lab diagnostics studies were performed. Therapy with ZOSTAVAX was reported as continued. The outcome of events was reported as not recovered/not resolved. This is one of several reports received from the same source. Additional information has been requested.
Metallic mouth; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration on 31Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 31Mar2021, the patient experienced metallic mouth. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of event metallic mouth was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
This study case was received from the investigator in a trial on 17 May 2013. A 32-year-old male subject whose past medical history included elevated cholesterol and eczema was found to have chest pain, unspecified 5 days after the subject had received the following vaccines on 20 November 2012: an injection of ACAM2000 (lot number, route and site of administration not reported), Anthrax 1 (manufacturer, lot number, route and site of administration not reported) and INFLUENZA, LIVE, INTRANASAL (manufacturer, lot number, route and site of administration not reported). Relevant laboratory data included on 25 November 2012: a normal Troponin I and an abnormal ECG. On 26 November 2012, the subject had a normal Echocardiogram. Lumbar puncture (spinal tap) and MRI of the brain, spinal cord and heart were not performed. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Left thigh are with redness and swelling to injection site since 3/18/2003 date of vaccination.